- Citations, last 5 years
- 11
- Works, last 5 years
- 15
- h-index
- 16
- Scientists listed
- 0
- Grants since 2016
- 248
Grants received
2016–2019 · research · R01
Genome Mining for Enediyne Natural Products from Actinomycetals
Ben Shen · Scripps (United States) · funded by National Institutes of Health
2016–2018 · research · R21
Development of a whole-brain cellular mapping approach in a genetic model of autism and intellectual disability
Konstantinos Meletis · Scripps (United States) · funded by National Institutes of Health
2016–2017 · research · R13
1st International SYNGAP1 Conference
Jimmy L Holder · Scripps (United States) · funded by National Institutes of Health
2016–2021 · cooperative agreement · UH3
Developing nonmuscle II inhibitors for substance use relapse
Patrick Robert Griffin · Scripps (United States) · funded by National Institutes of Health
2016–2020 · research · R33
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
Timothy Patrick Spicer · Scripps (United States) · funded by National Institutes of Health
2016–2017 · fellowship · F32
Role of RGS Proteins in Opioid Addiction
Brian S Muntean · Scripps (United States) · funded by National Institutes of Health
2016–2019 · research · R21
Hippocampal IncRNAs and Memory Consolidation
Sathya Puthanveettil · Scripps (United States) · funded by National Institutes of Health
2016–2018 · fellowship · F32
Development of Casein Kinase 1d and 1e Inhibitors for Treatment of Brain Cancer
Andrii Monastyrskyi · Scripps (United States) · funded by National Institutes of Health
2016–2018 · research · R21
Discovery of antibody biomarkers for Alzheimer’s Disease
Thomas J. Kodadek · Scripps (United States) · funded by National Institutes of Health
2016–2020 · research · R33
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
Timothy Patrick Spicer · Scripps (United States) · funded by National Institutes of Health
2016–2018 · research · R21
Manipulating IncRNAs to Disrupt Reconsolidation of Methamphetamine Associated Memories
Courtney A Miller · Scripps (United States) · funded by National Institutes of Health
2016–2024 · research · R35
Biology of memory
Ronald L Davis · Scripps (United States) · funded by National Institutes of Health
2016–2021 · research · R01
Regulation of mTOR signaling in the developing cerebral cortex as a point of convergence for multiple autism risk factors
Damon Theron Page · Scripps (United States) · funded by National Institutes of Health
2016–2019 · fellowship · F32
Structural Analysis of Corepressor Binding to PPARγ
Richard James Brust · Scripps (United States) · funded by National Institutes of Health
2016–2019 · research · R01
Kinase-mediated assembly of the mRNA entry channel in 40S ribosomes
Katrin Karbstein · Scripps (United States) · funded by National Institutes of Health
2016–2021 · research · R01
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
Jeffrey Aube · Scripps (United States) · funded by National Institutes of Health
2016–2024 · research · R35
Biology of memory
Ronald L Davis · Scripps (United States) · funded by National Institutes of Health
2016–2021 · research · R01
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
Jeffrey Aube · Scripps (United States) · funded by National Institutes of Health
2016–2019 · research · R01
Optimization of RORgamma-specific agonists as immune activators for a new immunotherapy approach for cancer
Patrick Robert Griffin · Scripps (United States) · funded by National Institutes of Health
2016–2018 · fellowship · F31
Understanding the basis of mRNA selectivity using ribosomes lacking Rps26
Max Ferretti · Scripps (United States) · funded by National Institutes of Health
2016–2020 · research · R01
Suite of high content assays for mitochondrial dynamics in neurons
Ronald L Davis · Scripps (United States) · funded by National Institutes of Health
2016–2018 · research · R21
Hepatitis C virus polyprotein processing efficiency regulates infectious virus production
Timothy Tellinghuisen · Scripps (United States) · funded by National Institutes of Health
2016–2021 · research · R01
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
Jeffrey Aube · Scripps (United States) · funded by National Institutes of Health
2016–2019 · fellowship · F32
Role of RGS Proteins in Opioid Addiction
Brian S Muntean · Scripps (United States) · funded by National Institutes of Health
2016–2019 · research · R01
Kinase-mediated assembly of the mRNA entry channel in 40S ribosomes
Katrin Karbstein · Scripps (United States) · funded by National Institutes of Health
2016–2018 · fellowship · F32
Development of Casein Kinase 1d and 1e Inhibitors for Treatment of Brain Cancer
Andrii Monastyrskyi · Scripps (United States) · funded by National Institutes of Health
2016–2021 · cooperative agreement · UH3
Developing nonmuscle II inhibitors for substance use relapse
Patrick Robert Griffin · Scripps (United States) · funded by National Institutes of Health
2016–2020 · research · R01
Rhes-SUMO circuitry in Huntington's Disease Pathogenesis
Srini Subramaniam · Scripps (United States) · funded by National Institutes of Health
2016–2020 · research · R01
Optimization of RORgamma-specific agonists as immune activators for a new immunotherapy approach for cancer
Patrick Robert Griffin · Scripps (United States) · funded by National Institutes of Health
2016–2017 · cooperative agreement · UH2
Developing nonmuscle II inhibitors for substance use relapse
Patrick Robert Griffin · Scripps (United States) · funded by National Institutes of Health
2016–2018 · fellowship · F32
An AAV Approach to Treating HIV
Matthew Ryan Gardner · Scripps (United States) · funded by National Institutes of Health
2016–2019 · career development · K01
MicroRNA-mediated mechanisms of social stress-potentiated drug seeking
Ashley M Blouin · Scripps (United States) · funded by National Institutes of Health
2016–2019 · career development · K01
MicroRNA-mediated mechanisms of social stress-potentiated drug seeking
Ashley M Blouin · Scripps (United States) · funded by National Institutes of Health
2015–2020 · research · R01
Impact of Pten mutations on brain growth and social behavioral development.
Damon Theron Page · Scripps (United States) · funded by National Institutes of Health
2015–2020 · grant · DP1
Using a disease-affected cell to synthesize its own drug
Matthew D Disney · Scripps (United States) · funded by National Institutes of Health
2015–2020 · research · R01
Towards HIV eradication using a novel Tat inhibitor
Susana T Valente · Scripps (United States) · funded by National Institutes of Health
2015–2022 · research · R01
Unraveling the role of PVH BDNF neurons in energy balance
Baoji Xu · Scripps (United States) · funded by National Institutes of Health
2015–2020 · research · R01
Single neuron biology, aging, and memory.
Ronald L Davis · Scripps (United States) · funded by National Institutes of Health
2015–2020 · research · R01
Evaluation of novel biomarkers of cognition in a model of sporadic developmental brain disorders and their application in efficacy testing of Ras pathway inhibitors
Gavin R Rumbaugh · Scripps (United States) · funded by National Institutes of Health
2015–2020 · grant · DP1
Using a disease-affected cell to synthesize its own drug
Matthew D Disney · Scripps (United States) · funded by National Institutes of Health
